Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine
- PMID: 3586130
- PMCID: PMC254236
- DOI: 10.1128/JVI.61.7.2150-2154.1987
Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine
Abstract
Intragastric inoculation with whole-virion vaccine of inactivated influenza virus resulted in production of hemagglutinin (HA)-specific immunoglobulin A (IgA) and IgG both in lung lavage fluids and in serum samples of mice. HA-specific IgA was the predominant isotypic antibody secreted in the lung lavage fluids (average IgA/IgG ratio, 13:1), whereas HA-specific IgG was the major antibody class in serum (average IgA/IgG ratio, 0.3:1). These responses were similar to the antibody responses stimulated by intranasal infection with live influenza virus. In vitro cultures of lymphoid cells from lungs and Peyer's patches, but not from spleens, in the presence of homologous antigen, from mice vaccinated intragastrically synthesized mostly HA-specific IgA. Mice immunized parenterally with inactivated influenza virus produced only IgG in lung lavage fluids and sera. Cultures of lymphoid cells from their spleens, but not their lungs, synthesized HA-specific IgG upon antigenic stimulation in vitro; neither synthesized IgA. These in vitro cell culture results, as well as the inverse relationship of IgA/IgG ratios in lung lavage fluids and sera, demonstrated that the IgA antibody in lung lavage fluids was actively synthesized locally in the lungs of intragastrically immunized mice. This finding was consistent with the migratory distribution of antigen-primed lymphoid cells from Peyer's patches to distant lymphoid tissue such as lung. Intragastric vaccination conferred protection against intranasal challenge with a lethal dose of virulent virus.
Similar articles
-
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.J Clin Microbiol. 1986 Jan;23(1):66-72. doi: 10.1128/jcm.23.1.66-72.1986. J Clin Microbiol. 1986. PMID: 3700610 Free PMC article.
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
-
Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.J Gen Virol. 1988 Nov;69 ( Pt 11):2779-84. doi: 10.1099/0022-1317-69-11-2779. J Gen Virol. 1988. PMID: 3183627
-
Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen.J Immunol. 2006 Jan 15;176(2):1122-30. doi: 10.4049/jimmunol.176.2.1122. J Immunol. 2006. PMID: 16394001
-
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602. Eur J Immunol. 1991. PMID: 1646112
Cited by
-
The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.J Virol. 2012 May;86(9):5089-98. doi: 10.1128/JVI.07205-11. Epub 2012 Feb 29. J Virol. 2012. PMID: 22379093 Free PMC article.
-
Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.Infect Immun. 1992 Apr;60(4):1482-8. doi: 10.1128/iai.60.4.1482-1488.1992. Infect Immun. 1992. PMID: 1548072 Free PMC article.
-
The regulation of pulmonary immunity.Adv Immunol. 1995;59:369-455. doi: 10.1016/s0065-2776(08)60634-3. Adv Immunol. 1995. PMID: 7484463 Free PMC article. Review.
-
Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.Pharm Res. 1993 Aug;10(8):1243-7. doi: 10.1023/a:1018992924025. Pharm Res. 1993. PMID: 8415415
-
Effects of haemorrhage on bacterial antigen specific pulmonary plasma cell function.Clin Exp Immunol. 1992 Apr;88(1):124-8. doi: 10.1111/j.1365-2249.1992.tb03050.x. Clin Exp Immunol. 1992. PMID: 1563098 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous